Skip to main content

JANE STREET GROUP, LLC

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in EWTX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$1,120,707
+$1,120,707 QoQ
Shares Held
35,578
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
15 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in EWTX Over Time

Shares Held

Position Value (USD)

Derivatives in EWTX

reported options exposure · as of Mar 31, 2026
CallValue
$431,550
CallShares
13,700
PutValue
$6,237,000
PutShares
198,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,247,243,084 across 314 Biotechnology names. EWTX ranks #114 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EWTX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,237,000 198,000
2026-03-31 $431,550 13,700
2026-03-31 $1,120,707 35,578
2025-12-31 $776,709 31,300
2025-12-31 $741,968 29,900
2025-09-30 $1,135,367 69,998
2025-06-30 $657,925 50,185
2025-03-31 $324,676 14,758
2025-03-31 $3,335,200 151,600
2025-03-31 $418,000 19,000
2024-12-31 $2,144,010 80,300
2024-12-31 $815,898 30,558
2024-12-31 $758,280 28,400
2024-09-30 $4,294,421 160,900
2024-09-30 $10,131,524 379,600
2024-09-30 $1,344,374 50,370
2024-06-30 $1,161,410 64,487
2024-03-31 $495,142 27,146
2023-12-31 $482,880 44,139
2023-06-30 $119,644 15,438
2023-03-31 $211,125 31,653
2022-12-31 $284,980 31,877
2022-09-30 $182,915 18,589
2022-06-30 $91,579 11,505